STOCK TITAN
  1. Home
  2. Sec-filings
  3. ANRO
  4. [ARS] Alto Neuroscience, Inc. SEC Filing

[ARS] Alto Neuroscience, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Alto Neuroscience, Inc.

ARS Filing - Alto Neuroscience, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Alto Neuroscience, Inc. (ANRO)

Acceptance Date: 2026-03-26T16:10:15.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Alto Neuroscienc

NYSE:ANRO

View ANRO Stock Overview →

ANRO Rankings

#3168 Ranked by Market Cap
N/A Ranked by Dividends

ANRO Latest News

Mar 16, 2026
Alto Neuroscience Announces $120 Million Private Placement Financing
Mar 16, 2026
Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
Mar 13, 2026
Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum
Feb 23, 2026
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Feb 13, 2026
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia

ANRO Latest SEC Filings

Mar 26, 2026
[DEF 14A] Alto Neuroscience, Inc. Definitive Proxy Statement
Mar 16, 2026
[8-K] Alto Neuroscience, Inc. Reports Material Event
Mar 16, 2026
[10-K] Alto Neuroscience, Inc. Files Annual Report
Mar 16, 2026
[8-K] Alto Neuroscience, Inc. Reports Material Event
Mar 3, 2026
[Form 4] Alto Neuroscience, Inc. Insider Trading Activity

ANRO Stock Data

665.11M
28.04M
Biotechnology
Pharmaceutical Preparations
Link
United States
MOUNTAIN VIEW